Kanak Raina
Impact in
- Hematology top 1%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
- Molecular Biology top 2%
- Protein Degradation and Inhibitors
- Ubiquitin and proteasome pathways
- Histone Deacetylase Inhibitors Research
Papers in
- Hematology 14
- Multiple Myeloma Research and Treatments 12
- Acute Myeloid Leukemia Research 3
-
- Protein Degradation and Inhibitors 17
- Ubiquitin and proteasome pathways 9
- Histone Deacetylase Inhibitors Research 2
- Co-authors
- Craig M. Crews (16 shared papers)Yimin Qian (10 shared papers)Andrew P. A. Crew (8 shared papers)Kevin G. Coleman (8 shared papers)Jing Wang (4 shared papers)James D. Winkler (4 shared papers)Hanqing Dong (4 shared papers)Jing Lü (3 shared papers)
- Journals
- Blood (5 papers)Leukemia (4 papers)Nature Chemical Biology (2 papers)ACS Chemical Biology (1 paper)ChemBioChem (1 paper)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Kanak Raina
20 papers receiving 3.4k citations
Kanak Raina's Hit Papers
Peers
Comparison fields: 5 of 77
- Hematology 970
- Molecular Biology 3.2k
- Oncology 1.1k
- Cell Biology 146
- Genetics 76
Countries citing papers authored by Kanak Raina
This map shows the geographic impact of Kanak Raina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kanak Raina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kanak Raina more than expected).
Fields of papers citing papers by Kanak Raina
This network shows the impact of papers produced by Kanak Raina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kanak Raina. The network helps show where Kanak Raina may publish in the future.
Co-authors
The 25 scholars most cited alongside Kanak Raina, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4 Hit paper breakdown → | 2015 | 947 |
| 2 | PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer Hit paper breakdown → | 2016 | 732 |
| 3 | 2015 | 394 | |
| 4 | 2011 | 354 | |
| 5 | 2017 | 208 | |
| 6 | 2017 | 161 | |
| 7 | 2017 | 152 | |
| 8 | 2017 | 104 | |
| 9 | 2012 | 90 | |
| 10 | 2019 | 84 | |
| 11 | 2018 | 74 | |
| 12 | 2014 | 72 | |
| 13 | 2010 | 60 | |
| 14 | 2024 | 41 | |
| 15 | 2018 | 37 | |
| 16 | 2015 | 4 | |
| 17 | 2016 | 3 | |
| 18 | 2016 | 2 | |
| 19 | 2017 | 1 | |
| 20 | 2025 | 1 |
About Kanak Raina
Kanak Raina is a scholar working on Hematology, Molecular Biology, Genetics, Oncology and Biotechnology, having authored 21 papers that have together received 3.5k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (17 papers), Multiple Myeloma Research and Treatments (12 papers), Ubiquitin and proteasome pathways (9 papers), Acute Myeloid Leukemia Research (3 papers), CAR-T cell therapy research (3 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Histone Deacetylase Inhibitors Research (2 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Hematology (970 citations), Molecular Biology (3.2k citations), Oncology (1.1k citations), Cell Biology (146 citations) and Genetics (76 citations). Kanak Raina has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Craig M. Crews, Yimin Qian, Andrew P. A. Crew, Kevin G. Coleman, Jing Wang, James D. Winkler, Hanqing Dong, Jing Lü, Martha Altieri and John F. Hines. Their work appears in journals such as Blood, Leukemia, Nature Chemical Biology, ACS Chemical Biology and ChemBioChem.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.